Cinnie Yentia Soekojo

Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis

Ömer An, Tae‐Hoon Chung, Jing Yuan Chooi et al. · Blood · 2018 · 106 citations · Full text

Medicine, Molecular Biology, Oncology +14

Genomic characterization of functional high-risk multiple myeloma patients

Cinnie Yentia Soekojo, Tae‐Hoon Chung, M.S. Furqan et al. · Blood Cancer Journal · 2022 · 40 citations · Full text

Medicine, Hematology, Oncology +16

Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma

Yunlu Jia, Jianbiao Zhou, Tze King Tan et al. · Blood Cancer Journal · 2021 · 33 citations · Full text

Medicine, Molecular Biology, Oncology +16

Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)—a trial by the Asian Myeloma Network

Cinnie Yentia Soekojo, Shang‐Yi Huang, Chor Sang Chim et al. · Blood Cancer Journal · 2019 · 21 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Surgical Management of Multiple Myeloma With Symptomatic Involvement of the Spine

Helena Milavec, Nivetha Ravikumar, Nicholas Syn et al. · The International Journal of Spine Surgery · 2020 · 19 citations · Full text

Medicine, Oncology, Surgery +13